Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein with KRAB and SCAN domains 2 (ZKSCAN2) is a member of the ZSCAN subgroup of the large zinc finger protein family. Zinc finger proteins are the largest family of transcription factors in humans, characterized by C2H2-type zinc finger domains that bind to DNA and regulate gene expression[1][2][3]. ZKSCAN2 contains both a Krüppel-associated box (KRAB) domain, which functions in transcriptional repression, and a SCAN domain, which mediates protein–protein interactions, including dimerization with other transcription factors[3]. While the broad ZSCAN family has been implicated in various cancers, immune responses, and diverse cellular processes, the specific biological roles and disease associations of ZKSCAN2 have not been well-characterized in current literature. No FDA-approved drugs, direct disease biomarkers, or unique safety considerations have been reported for this protein as of now.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein with KRAB and SCAN domains 2 (ZKSCAN2).